Pharmaceutical Exporter From India to New Zealand

Pharmaceutical Exporter From India to New Zealand- Lifecare Psychiatry Care is a legally registered pharma company that exports the highest quality Neuro and Psychiatry drugs in New Zealand, as per the Foreign Trade Policy. The firm is well-known for its extensive and sanitary manufacturing facilities and services. We use DCGI and FSSAI-approved drugs that are delivered by a legally certified drug vendor for quality manufacture. Anti-depressants, Anti-Epileptics, Anxiolytics, Anti-Addiction, Mood Stabilizers, Antiparkinsonians, Anti-Psychotics, Anti-Migraine, and other neuropsychiatric medications are available from our company. We are the leading Pharmaceutical Exporter From India to New Zealand-  because we adhere to all tight requirements from top-quality manufacturing to exporting across Auckland, Christchurch, Wellington, Hamilton, Tauranga etc.

Lifecare Psychiatry Care is the world's leading Pharmaceutical Exporter From India to New Zealand, with products and services distributed in more than 20 countries. All Neuro and Psychiatry products are manufactured in a state-of-the-art manufacturing facility that employs cutting-edge technology from well-known brands such as GLATT, WATERS, BOSCH, and others. We are accredited by many health and manufacturing institutes such as ISO, WHO, GMP, GLP, HACCP, GCCLP, and others for satisfying all quality criteria and legal licenses. We offer Pharmaceutical Exporter From India to New Zealand, as well as third-party manufacturing, contract manufacturing, and private labelling services at cheap costs, as this country is prone to anxiety and depression.

Why Neuro and Psychiatry Medications are Highly demanded in New Zealand

In New Zealand, mental health and addiction issues are frequent, and they can affect anyone. According to prevalence studies, 50–80 percent of New Zealanders will have mental health or addiction issues, or both, at some point in their lives. In New Zealand, anxiety and sadness are extremely common. This year, one out of every five of us will be affected. One in every six New Zealanders will suffer depression at some point in their lives, and one in every four New Zealanders will be impacted by an anxiety condition at some point in their lives. 15 percent of the population will be affected at any given time.

At some point in their life, an estimated 636,000 adults (17%) have been diagnosed with a mood illness and/or anxiety condition (including depression, bipolar disorder, and/or anxiety disorder). In addition, 225,000 persons (6.2%) said they had experienced emotional anguish in the previous four weeks (including anxiety, confused emotions, depression, or rage). As a result, we can observe that adults in this country are dealing with mental health concerns and are looking for better treatment options.

Our Associates / Vendors